Beware of Medical Counterfeits!

A man looks at a tablet in the kitchen.

Protecting Patients Is a Priority for Bayer

Germany has a secure healthcare system. However, patients who buy online or abroad increasingly fall prey to counterfeit drug scams. Bayer is active in the fight against trade with illegal medicines. Counterfeit drugs are a global threat. Worst case, such fakes can endanger the health of unsuspecting users or even be life-threatening.

 

apothekerin-und-patientin

 

On this page you will find information about how to protect yourself from fake medicines.

 

Warning about stolen Nubeqa® in Brazil (June 12, 2023)

 

The Brazilian Health Authority issued a warning concerning stolen Nubeqa®. (Portuguese language only, order no. 103 in the list of stolen goods)

 

We know that the illegal marketing of stolen medicines poses a serious threat to public health and is a criminal offence. Therefore, we feel the need to alert the market of what happened to avoid the dissemination and commercialization of this batch of the product. Only the following Nubeqa® batch (all packages of this batch) is affected:

 

Nubeqa®

Lot: 2147154

Fab: 13/02/2023

Val: 31/01/2026

 

Nubeqa

 

Police authorities are investigating the case, which was registered in Police Report No: GW9853-1/2023.

 

From the safety perspective, Bayer recommends not to use the stolen product which has left the legal supply chain and might be subject to inappropriate storage and handling conditions affecting its quality, safety and efficacy.

 

If you have such a package of the above mentioned batch of Nubeqa®, please contact your local competent health authorities.

Warning about falsified medicine (Aspirin Protect 100 mg 30 Tablets, batch BT13J11) in the official legal distribution chain in Kosovo (May 27, 2022):


Falsified products have been identified in Kosovo, all marked with the same variable data, imitating genuine Bayer Aspirin Protect 100 mg 30 Tablets packages, batch code BT13J11, expiry date 04 2025.

The packages were detected in the legal supply chain in a pharmacy.

 

How to identify the falsified products is explained in the corresponding document.

 

From the safety perspective, Bayer recommends not to use the counterfeit / falsification in the present case which is a product out of specifications.

 

If you need support in identifying such a potentially falsified package, please contact us immediately as indicated in the corresponding document.

Warning about falsified medicine (Gamimune N.5%) marketed with the company logo in Brazil (October 21, 2022)

 

The Brazilian Health Authority issued a warning (Portuguese language only) concerning the falsified product Gamimune N.5%. The product Gamimune N.5% is marketed with Bayer’s company logo and name, but it is not an authentic product manufactured by Bayer. There is neither such product registered by Bayer for the Brazilian market nor Bayer manufactures such a product.

 

From the safety perspective, Bayer recommends not to use the counterfeit / falsified / phantasy product which is not a registered authentic Bayer product.

 

If you have such a package, please contact your local competent health authorities.

Brochures and Flyers